An analysis of data about aspirin and nonsteroidal anti-inflammatory drug use by more than 300,000 people appears to indicate that using aspirin was linked to a 41% lower risk of liver cancer and a 45% reduced chance of dying from chronic liver disease. Although nonsteroidal anti-inflammatory drug use was linked to a 26% lower risk of dying from liver disease, it did not curb the likelihood of liver cancer, researchers said. The findings appear in the Journal of the National Cancer Institute.